OP2 Organizational Impact Model Associated With Switching From Intravenous (IV) to Subcutaneous (SC)
Abstract
Authors
H Hadjrabia D Avot L Latreche A Doutriaux
H Hadjrabia D Avot L Latreche A Doutriaux
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now